Skip to main content
1 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Speak to Our Experts
3 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Pharmaceutical Microbiology Testing

Auriegene Pharmaceutical Services pharmaceutical microbiology testing department has a BSL-2 compliant lab and a dedicated in-vivo facility for bacterial and fungal infection murine disease models. The team has vast experience in anti-infective drug discovery projects and ran several collaboration projects with innovator pharma companies to discover anti-bacterial and anti-fungal agents. Established in-vitro time kill kinetics bioequivalence assays for generic products for regulatory submission.

 

Why Aurigene Pharmaceutical Services for Pharmaceutical Microbiology Testing?

Submissions to the US FDA and DCGI

Highly Qualified & Experienced Scientists

Audited by the US FDA with Zero 483 in 2019

BSL-2 Compliant Microbiology Lab

 

In-vitro pharmaceutical microbiology testing services include:

 
  • Pharmacodynamic studies: Drug-organism interaction
  • MIC and MBC: Susceptibility indicators; major parameters used to quantify activity of an antibacterial agent against target pathogen
  • Time kill kinetics: Information on the time course and rate of antimicrobial activity
  • PAE and PA-SME: Information on persistent effects of antibacterial agents
  • Resistance development and mutation frequency: Information on rate of resistance
  • Others: Antimicrobial combination/effect of serum proteins on MIC/ biofilm studies
 

Our dedicated Microbiology labs offer a wide range of infectious models which can be tailored as per customer requirements

 

In-vivo Pharmaceutical Microbiology Testing 

 
  • Systemic infection models: Acute lethal model to generate POC and determine ED50 - primary screening
  • Respiratory tract infection models: Test efficacy of NCEs in highly vascularized tissue like lungs
  • Thigh infection models: Test efficacy of NCEs in poorly vascularized tissues like thighs
  • Urinary tract infection models: Test ability of NCEs to clear UTIs
  • Organ burden models: Test ability of NCEs to clear disseminated infection